1. World Health Organization. Global health sector strategies on, respectively, HIV, viral hepatitis and sexually transmitted infections for the period 2022-2030. (2022). Retrieved from https://iris.who.int/bitstream/handle/10665/360348/9789240053779-eng.pdf?sequence=1. Accessed July 12, 2023.
2. US Department of Health and Human Services, Centers for Disease Control and Prevention. Viral Hepatitis Surveillance—United States, (2020). Retrieved from https://www.cdc.gov/hepatitis/statistics/2020surveillance/index/htm. Accessed July 12, 2023.
3. Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial;Grebely;The Lancet. Gastroenterology & Hepatology,2018
4. Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis. The lancet;Hajarizadeh;Gastroenterology & Hepatology,2018
5. Utilising an access to care integrated framework to explore the perceptions of hepatitis C treatment of hospital-based interventions among people who use drugs;Levander;The International Journal on Drug Policy,2021